Mohit Bansal

Q: What is Mohit Bansal's success rate?

Mohit Bansal currently has a success rate of 84.54393970536304.

Q: What is the average return of Mohit Bansal's calls?

Their stock ratings have generated an average return of 11.683304940152729.

Wells Fargo | Healthcare

Mohit Bansal is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #2034 out of 4718 analysts, they have issued 47 stock ratings with a success rate of 84.54% and an average return of 11.68%.

Mohit Bansal has a well-established track record, with 47 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 84.54% and an average return of 11.68%, underscoring their expertise and ability to identify winning opportunities for investors.

#2034

Out of 4718

Total Ratings

+84.54%

Success Rate

+11.68%

Average Return

Recent Ratings Analysis

ABBV

Buy

Jul 10, 2026

Target

$295.00

Current

$249.91

Performance

—

Mohit Bansal rated ABBV as Overweight on Jul 10, 2026, setting a price target of 295. Shares have remained stable near 249.91, leaving the 295 target still in play.

MRK

Buy

Jul 08, 2026

Target

$150.00

Current

$125.07

Performance

-0.73%

On Jul 08, 2026, MRK was given a Overweight rating by Mohit Bansal, with a target price of 150. The stock traded sideways with a -0.73% move, keeping the bullish thesis unresolved.

TVTX

Buy

Jun 12, 2026

Target

$65.00

Current

$58.47

Performance

12.36%

TVTX received a Overweight rating from Mohit Bansal on Jun 12, 2026, aiming for 65. Momentum has favored the Buy call, with shares climbing from 58.47 to 58.47, rewarding those who trusted the recommendation.

REGN

Hold

May 18, 2026

Target

$700.00

Current

$667.95

Performance

6.08%

On May 18, 2026, Mohit Bansal published a Equal-Weight outlook on REGN, with a target of 700. The Hold call missed some of the bullish momentum as shares advanced toward 700.

MIST

Buy

May 14, 2026

Target

$7.00

Current

$1.31

Performance

-19.63%

Mohit Bansal on May 14, 2026 assigned MIST a Overweight rating, with a price target of 7. The call has struggled to gain traction, with shares losing 19.63%.

BNTX

Buy

May 06, 2026

Target

$140.00

Current

$92.98

Performance

-2.39%

On May 06, 2026, Mohit Bansal reaffirmed BNTX with a Overweight rating, targeting 140. Market indecision has kept the 140 target in a holding pattern.

JAZZ

Buy

May 06, 2026

Target

$265.00

Current

$246.91

Performance

8.02%

JAZZ was rated Overweight by Mohit Bansal on May 06, 2026, with a price objective of 265. A bullish response from the market helped close the gap of 18.09 to the target.

BIIB

Buy

Apr 20, 2026

Target

$250.00

Current

$198.91

Performance

8.49%

On Apr 20, 2026, Mohit Bansal initiated coverage on BIIB with a Overweight rating and target of 250. The stock’s climb of 8.49% since the call highlights the foresight in the rating.

HALO

Hold

Feb 19, 2026

Target

$75.00

Current

$78.62

Performance

9.13%

Mohit Bansal issued a Equal-Weight recommendation for HALO on Feb 19, 2026, price target set at 75. A neutral call gave way to stronger-than-expected performance, closing in on 75.

AMGN

Hold

Feb 19, 2026

Target

$375.00

Current

$363.62

Performance

-3.16%

On Feb 19, 2026, AMGN was evaluated by Mohit Bansal, who gave a Equal-Weight rating and target of 375. Hold sentiment was validated by subdued trading with no breakout beyond 363.62.

BMRN

Buy

Feb 18, 2026

Target

$75.00

Current

$59.97

Performance

-3.01%

Mohit Bansal rated BMRN as Overweight on Feb 18, 2026, setting a price target of 75. Shares have remained stable near 59.97, leaving the 75 target still in play.

NBIX

Buy

Feb 13, 2026

Target

$180.00

Current

$180.55

Performance

45.46%

On Feb 13, 2026, NBIX was given a Overweight rating by Mohit Bansal, with a target price of 180. The stock rallied 45.46% after the rating, narrowing the gap to the target of 180 and validating the bullish stance.

GILD

Buy

Feb 11, 2026

Target

$165.00

Current

$134.84

Performance

-13.45%

GILD received a Overweight rating from Mohit Bansal on Feb 11, 2026, aiming for 165. The rating hasn’t played out as hoped, with the stock trading 13.45% below expectations.

BMY

Hold

Feb 06, 2026

Target

$60.00

Current

$57.94

Performance

-6.53%

On Feb 06, 2026, Mohit Bansal published a Equal-Weight outlook on BMY, with a target of 60. Weakness in the stock, now at 57.94, supported the conservative rating.

LLY

Buy

Feb 05, 2026

Target

$1280.00

Current

$1216.95

Performance

19.21%

Mohit Bansal on Feb 05, 2026 assigned LLY a Overweight rating, with a price target of 1280. The Buy call aligned well with market performance, producing a gain of 19.21%.

IRWD

Hold

Jan 05, 2026

Target

$5.00

Current

$4.67

Performance

1.74%

On Jan 05, 2026, Mohit Bansal reaffirmed IRWD with a Equal-Weight rating, targeting 5. The neutral call matched muted market action of 1.74%.

VRTX

Buy

Dec 10, 2025

Target

$515.00

Current

$496.50

Performance

11.66%

VRTX was rated Overweight by Mohit Bansal on Dec 10, 2025, with a price objective of 515. A bullish response from the market helped close the gap of 18.50 to the target.

MLYS

Buy

Nov 11, 2025

Target

$55.00

Current

$28.96

Performance

-38.53%

On Nov 11, 2025, Mohit Bansal initiated coverage on MLYS with a Overweight rating and target of 55. The Buy call has yet to be validated as shares remain 26.04 away from the target.

SMMT

Buy

Dec 11, 2024

Target

$30.00

Current

$15.48

Performance

-17.53%

Mohit Bansal issued a Overweight recommendation for SMMT on Dec 11, 2024, price target set at 30. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

VERA

Buy

Nov 21, 2024

Target

$70.00

Current

$42.45

Performance

-9.74%

On Nov 21, 2024, VERA was evaluated by Mohit Bansal, who gave a Overweight rating and target of 70. Investors saw limited payoff as shares fell short of the 70 target.

PFE

Hold

Jul 31, 2024

Target

$30.00

Current

$24.25

Performance

-20.60%

Mohit Bansal rated PFE as Equal-Weight on Jul 31, 2024, setting a price target of 30. The cautious Hold call aligned with subsequent weakness, as shares slipped 20.60%.

Frequency Asked Questions

Who is Mohit Bansal?

Mohit Bansal is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Mohit Bansal's success rate?

Mohit Bansal currently has a success rate of +84.54%.

How many ratings has Mohit Bansal issued?

Mohit Bansal has issued 47 stock ratings so far.

What is the average return of Mohit Bansal's calls?

Their stock ratings have generated an average return of +11.68%.

What is Mohit Bansal's ranking?

Mohit Bansal is ranked #2034 out of 4718 analysts.

What types of ratings does Mohit Bansal give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mohit Bansal?

You can follow Mohit Bansal by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mohit Bansal?

Their latest rating was a Buy on ABBV issued on 2026-07-10.